Wayne, PA, United States of America

Joel Kauffman


Average Co-Inventor Count = 2.3

ph-index = 1

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 2002-2010

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Joel Kauffman

Introduction

Joel Kauffman is a notable inventor based in Wayne, Pennsylvania, with a significant impact in the field of optical materials and pharmaceuticals. He holds three patents that showcase his innovative approach to solving complex problems in these industries.

Latest Patents

Kauffman's latest patents include groundbreaking work on compounds that absorb ultraviolet light. These compounds are designed to absorb light in the 380 nm to 400 nm range while avoiding absorption in the blue light range, which imparts yellowness in the 410-420 nm range. This innovation has suitable refractive characteristics that are useful in the preparation of optical resins or plastics, particularly for the manufacture of ophthalmic lenses. Additionally, he has developed methods for making these compounds and the optical lenses that contain them. Another significant patent involves halogenated antituberculosis agents, which contribute to advancements in pharmaceutical applications.

Career Highlights

Throughout his career, Kauffman has worked with prominent organizations, including Essilor International and the University of Sciences of Philadelphia. His work has not only advanced the field of optics but has also contributed to public health through his pharmaceutical innovations.

Collaborations

Kauffman has collaborated with notable individuals in his field, including Farzad Kobarfard and Peter T. Litak. These collaborations have further enriched his research and development efforts.

Conclusion

Joel Kauffman's contributions to the fields of optics and pharmaceuticals through his innovative patents demonstrate his commitment to advancing technology and improving lives. His work continues to influence both industries significantly.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…